Biosimilars in Cancer

Erscheinungsjahr 2026
ISBN: 978-0-443-45593-3
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 191 mm x 235 mm, Gewicht: 450 g

Biosimilars in Cancer is a comprehensive resource addressing the role of biosimilars in treating various cancer types. This book offers a succinct yet thorough overview of current trends in oncology, covering 21 different cancers from liver to breast cancer. Each chapter provides detailed insights into the latest trends, fundamental facts, and practical and clinical data, making it an invaluable tool for academics and practitioners. By compiling this rich content into a single, accessible volume, the book empowers researchers and clinicians to enhance their understanding, and improve patient outcomes through the effective use of biosimilars in oncology. Targeted primarily at pharmaceutical researchers, biomedical scientists, and clinicians, Biosimilars in Cancer supports the growing oncology biosimilars market. It also provides critical insights for those involved in cancer diagnostics and clinical trials, helping them stay ahead in this rapidly progressing field.

Autoren/Hrsg.

Shegokar, Ranjita

Pathak, Yashwant

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Liver Cancer: Biosimilars in Cancer Research
2. Pancreatic Cancer: Biosimilars in Cancer Research
3. Heart Cancer: Biosimilars in Cancer Research
4. Bone Cancer: Biosimilars in Cancer Research
5. Spleen Cancer: Biosimilars in Cancer Research
6. ENT Cancer: Biosimilars in Cancer Research
7. Brain/CNS Cancer: Biosimilars in Cancer Research
8. Skin Cancer: Biosimilars in Cancer Research
9. Lung Cancer: Biosimilars in Cancer Research
10. Thorax Cancer: Biosimilars in Cancer Research
11. Thyroid Cancer: Biosimilars in Cancer Research
12. Kidney-Adrenal Cancer: Biosimilars in Cancer Research
13. Urinary Tract Cancer: Biosimilars in Cancer Research
14. Breast Cancer: Biosimilars in Cancer Research
15. Colorectal Cancer: Biosimilars in Cancer Research
16. Blood Cancer: Biosimilars in Cancer Research
17. Prostate Cancer: Biosimilars in Cancer Research
18. Ovarian Cancer: Biosimilars in Cancer Research
19. Stomach and Intestinal Cancer: Biosimilars in Cancer Research
20. Pleura and Peritoneum Cancer: Biosimilars in Cancer Research
21. Oral Cancer: Biosimilars in Cancer Research

Über Autor(innen)

Shegokar, Ranjita
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)

Pathak, Yashwant
Yashwant Pathak, is Professor, Taneja College of Pharmacy, at the University of South Florida. Tampa, USA. His area of research is nanotechnology, drug delivery systems and nutraceuticals. He is also Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.